Limited time offer
Use code AV15 at checkout for 15% off & Free expedited shipping
Use code AV15 at checkout for 15% off & Free expedited shipping
(Weekly Injection)
One of the strongest weight‑loss momentum for many adults—dual‑action GLP‑1/GIP with a simple, once‑weekly routine.
What it is
Tirzepatide (brand names Mounjaro and Zepbound) offers significant health benefits primarily in managing type 2 diabetes and promoting substantial weight loss. Its dual-action mechanism as a GIP and GLP-1 receptor agonist also contributes to several related cardiometabolic improvements.
Who it’s for
Adults who want a potent weekly option and a straightforward plan.
U.S.-Licensed Providers
503A Pharmacy Approved
HIPAA Compliant
Free Discreet Shipping
From $299/mo
As low as with 6-month plan
4.9
from 2,400+ patients
LegitScript-certified
Licensed in all 50 states
Landmark trials show substantial average loss vs placebo; head‑to‑head data favored tirzepatide over semaglutide.
Earlier fullness, fewer snack impulses, easier “no thanks.”*
Clinician‑guided titration and portal check‑ins keep it smooth.
Clear pricing and refill control.
Each of these applies to a specific group. A clinician confirms whether any of them describes you.
In clinical trials, adults with obesity using tirzepatide lost an average of 15% to over 20% of their initial body weight over 72 weeks, significantly more than with diet and exercise alone or other medications like semaglutide. This is primarily driven by reduced appetite, slowed gastric emptying, and enhanced metabolism.
Approved for
Adults with type 2 diabetes
Tirzepatide is FDA-approved for managing type 2 diabetes and has been shown to lower HbA1c levels (a measure of long-term blood sugar) more effectively than other diabetes medications, including insulin and semaglutide.
Approved for
Obesity, or overweight with a related condition
Tirzepatide (Zepbound brand) is also FDA-approved for treating moderate to severe OSA in adults with obesity, by lowering the number of breathing disruptions during sleep and reducing body weight.
Approved for
Type 2 diabetes, or obesity or overweight with established heart disease
Most programs make you wait weeks between labs, review and shipping. We compress the whole thing into a single week.
01 — INTAKE
Tell us about your symptoms and health history. No lab work required to begin.
02 — REVIEW
Your provider reviews your health history and determines whether treatment is appropriate — labs only if your provider needs them.
03 — DELIVERY
If prescribed, your medication ships to your door in days, in plain packaging.
Choose your supply. Everything below is included at both price points.
Month-to-Month
3-Month Plan
$199
/month
Custom compounded medication
$297
/month
$99 per month, 3 months paid up front totaling $297. Personalized Compounded Medication
$99
/month
Billed $99 every month. Cancel anytime.
$960 less per year than monthly
+$35 at-home lab kit, credited to your first month.
Month-to-Month
3-Month Plan
$249
/month
$447
/month
149 per month, 3 months paid up front for 447 total. Personalized Compounded Medication.
$99
/month
Billed $99 every month. Cancel anytime.
$960 less per year than monthly
+$35 at-home lab kit, credited to your first month.
Every number below is what each program advertises publicly — the entry price first, then what that price actually covers.
| Name | Details |
|---|---|
| RO Body | $45 first month, then $145/mo membership; medication cost not included (cash‑pay GLP‑1s start $349/mo) |
| Hims | GLP‑1 plans advertised from $199/mo with 6‑month prepay; non‑GLP‑1 oral kits from $69/mo (10‑month prepay). |
| Fridays | “One transparent monthly price” with coaching included (site lists all‑in monthly pricing structure). |
| Eden | GLP‑1s advertised “$139 first month, then $239/mo” on select plans. |
| Ruiget | Promotes non‑GLP‑1 oral combos for weight vs. GLP‑1 injections. (Membership options from $99/mo noted in support article.) |
Beyond its primary approved uses, ongoing research is exploring other potential benefits:
Tirzepatide has shown promising results in reducing cardiovascular risk factors. Studies indicate it can lower blood pressure and cholesterol levels, and research from the SUMMIT trial shows it reduces the risk of cardiovascular death or worsening heart failure in patients with obesity and a specific type of heart failure (HFpEF).
It helps improve cholesterol profiles by reducing total cholesterol, LDL ("bad") cholesterol, and triglycerides, while increasing HDL ("good") cholesterol levels.
The medication has demonstrated anti-inflammatory properties, lowering key inflammatory markers associated with chronic diseases, which may contribute to its broad metabolic benefits.
Beyond weight on the scale, tirzepatide reduces visceral fat (dangerous belly fat around organs) and can improve insulin sensitivity, helping the body process sugar more efficiently.
Ongoing research is exploring its use in treating other conditions linked to obesity and inflammation, such as metabolic dysfunction-associated steatohepatitis (MASH, a type of fatty liver disease), polycystic ovary syndrome (PCOS), and even certain neuroprotective effects.
The meter on each card shows how far the evidence has actually got.
Approved
FDA accelerated approval in adults with moderate to advanced liver fibrosis.
Active trials
Being investigated for slowing cognitive decline in early Alzheimer's disease.
Early studies
Improved insulin sensitivity, weight loss and more regular cycles.
Early signal
Reduced inflammatory markers, with possible benefit to heart, liver and kidneys.
Patient-reported
Reported by some patients following weight loss and better health control.
Semaglutide is a prescription medication and should be used under the guidance of a healthcare professional, alongside a reduced-calorie diet and increased physical activity.
Straight answers on how Ascend Vitality works, what’s included, and what to expect after checkout.
